These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 18023328
1. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Takahashi-Yanaga F, Sasaguri T. Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328 [Abstract] [Full Text] [Related]
2. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity. Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM, Gelderblom WC. Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956 [Abstract] [Full Text] [Related]
3. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. Ong CS, Zhou J, Ong CN, Shen HM. Cancer Lett; 2010 Dec 08; 298(2):167-75. PubMed ID: 20655656 [Abstract] [Full Text] [Related]
4. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T. Exp Cell Res; 2005 Nov 01; 310(2):426-33. PubMed ID: 16153639 [Abstract] [Full Text] [Related]
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway. Xu G, Li Y, Yoshimoto K, Wu Q, Chen G, Iwata T, Mizusawa N, Wan C, Nie X. Toxicol Lett; 2014 Jan 30; 224(3):362-70. PubMed ID: 24231000 [Abstract] [Full Text] [Related]
6. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Masamha CP, Benbrook DM. Cancer Res; 2009 Aug 15; 69(16):6565-72. PubMed ID: 19638577 [Abstract] [Full Text] [Related]
7. HBx protein modulates PI3K/Akt pathway to overcome genotoxic stress-induced destabilization of cyclin D1 and arrest of cell cycle. Mukherji A, Janbandhu VC, Kumar V. Indian J Biochem Biophys; 2009 Feb 15; 46(1):37-44. PubMed ID: 19374252 [Abstract] [Full Text] [Related]
8. PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells. Yang Y, Wu J, Cai J, He Z, Yuan J, Zhu X, Li Y, Li M, Guan H. Int J Cancer; 2015 Feb 15; 136(4):E39-50. PubMed ID: 25142862 [Abstract] [Full Text] [Related]
9. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG. J Biol Chem; 2000 Oct 20; 275(42):32649-57. PubMed ID: 10915780 [Abstract] [Full Text] [Related]
10. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Shin HS, Lee HJ, Nishida M, Lee MS, Tamura R, Yamashita S, Matsuzawa Y, Lee IK, Koh GY. Circ Res; 2003 Aug 22; 93(4):302-10. PubMed ID: 12869389 [Abstract] [Full Text] [Related]
11. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation. Chen B, Pan H, Zhu L, Deng Y, Pollard JW. Mol Endocrinol; 2005 Aug 22; 19(8):1978-90. PubMed ID: 15845746 [Abstract] [Full Text] [Related]
12. GSK-3beta-dependent destabilization of cyclin D1 mediates replicational stress-induced arrest of cell cycle. Mukherji A, Janbandhu VC, Kumar V. FEBS Lett; 2008 Apr 02; 582(7):1111-6. PubMed ID: 18328826 [Abstract] [Full Text] [Related]
13. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW. BMC Cell Biol; 2006 Aug 30; 7():33. PubMed ID: 16942622 [Abstract] [Full Text] [Related]
14. Transcriptional and post-transcriptional down-regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin. He S, Zhu W, Zhou Y, Huang Y, Ou Y, Li Y, Yan G. J Cell Biochem; 2011 Sep 30; 112(9):2241-9. PubMed ID: 21480364 [Abstract] [Full Text] [Related]
15. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A. Cancer Res; 2006 Dec 01; 66(23):11462-70. PubMed ID: 17145894 [Abstract] [Full Text] [Related]
16. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor. Chiang WC, Teng CM, Lin SL, Chen YM, Tsai TJ, Hsieh BS. Eur J Pharmacol; 2005 Jul 04; 517(1-2):1-10. PubMed ID: 15950964 [Abstract] [Full Text] [Related]
17. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells. Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T. J Biol Chem; 2003 Mar 14; 278(11):9663-70. PubMed ID: 12522140 [Abstract] [Full Text] [Related]
18. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K. Carcinogenesis; 2003 Mar 14; 24(3):435-42. PubMed ID: 12663502 [Abstract] [Full Text] [Related]
19. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer. Zhang J, Gill AJ, Issacs JD, Atmore B, Johns A, Delbridge LW, Lai R, McMullen TP. Hum Pathol; 2012 Jul 14; 43(7):1044-50. PubMed ID: 22204713 [Abstract] [Full Text] [Related]
20. Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line. Xia JJ, Pei LB, Zhuang JP, Ji Y, Xu GP, Zhang ZP, Li N, Yan JL. J Int Med Res; 2010 Jul 14; 38(4):1294-304. PubMed ID: 20926002 [Abstract] [Full Text] [Related] Page: [Next] [New Search]